Role Summary
Executive Director of Clinical Development (Rare Disease) leads and oversees the clinical development program for Recursion’s rare disease portfolio, translating scientific insights into IND-to-POC programs. You will develop integrated development strategies, contribute to regulatory submissions, and guide trial design and execution with scientific rigor. Location: New York City or Salt Lake City; hybrid work arrangement requiring 50% in the office; relocation support available.
Responsibilities
- Oversee the development of first-in-class/first-in-disease molecules in precision rare disease
- Generate and continually refine the integrated clinical development strategy for Recursion’s rare disease medicine portfolio from IND to POC
- Contribute to regulatory submissions and participate in regulatory agency meetings
- Utilize strong therapeutic area expertise to enhance innovation and efficiency in clinical trial design and execution
- Deliver medical, disease-specific, and development perspective into specific research programs or broader research initiatives
- Provide scientific and medical expertise for business development assessments and due diligences
Qualifications
- Medical Degree required and MD/PhD preferred
- 5+ years of experience developing, executing and analyzing Phase 1/2 rare disease trials and preferably within a biotech or pharmaceutical company
- Deep knowledge and understanding of rare and genetic diseases; precision drug development paradigms, clinical pharmacology with technical and regulatory approaches
- Strong networks and connections to external experts and key opinion leaders. Ability to form effective collaborations with external scientific community, academia and CROs
- Effective skills directed toward driving collaboration, achieving results, influencing, and resolving conflicts across internal and external stakeholders
- Highly motivated, decisive, and results-oriented individual who is proactive, resourceful, and efficient with the flexibility and creativity to excel in and contribute to a rapidly growing drug discovery and development company